TraceLink Named Fortress Cybersecurity Awards Finalist for Enabling the Transformation to a Secure, Auditable Agentic Supply Chain Operating Model
OPUS Platform and OPUS Agents recognized for enabling no-code AI agents to operate as permissioned, traceable participants in regulated pharmaceutical supply chain operations Summary TraceLink has been named a finalist in the 2026 Fortress Cybersecurity Awards for OPUS and OPUS Agents. The recognition highlights TraceLink's ability to support agentic supply chain...
Haisco Enters into Exclusive License Agreement with Nuvectis for Two Drug Candidates in Oncology and Complement Indications
BEIJING, June 23, 2026 /PRNewswire/ -- On June 23, 2026 (Beijing time), Haisco Pharmaceutical Group Co., Ltd. (Ticker Code: 002653) announced that it has entered into an exclusive licensing agreement with Nuvectis, a U.S. biotechnology company. Under the agreement, Haisco has granted Nuvectis the exclusive rights to develop, manufacture, and commercialize its independently developed innovative drug HSK42360 worldwide, excluding...
Chenwei Medical Showcases Advanced ICU Ventilators, Anesthesia Workstations and Emergency Transport Ventilator Solutions at WHX Miami 2026
MIAMI, June 23, 2026 /PRNewswire/ -- Following its participation in the AMCI International Critical Care Congress in Colombia, Chenwei Medical presented its latest innovations in ICU ventilation, anesthesia systems and emergency respiratory care at WHX Miami 2026. Chenwei Medical at WHX Miami 2026 (Booth C53), showcasing advanced Anesthesia Systems, Ventilators, Patient Monitors, and Smart Healthcare Solutions. ...
EpiVax Announces Laboratory Expansion and Streamlined, NAM-Centric In Vitro Services
PROVIDENCE, R.I., June 23, 2026 /PRNewswire/ -- EpiVax, Inc., a recognized leader in immunogenicity risk assessment, announces the expansion of its laboratory facilities at its Providence, RI headquarters. The upgraded space has more than doubled the company's laboratory footprint, expanding the CRO's capacity to support advanced immunological testing. This investment reflects growing demand...
TriNetX LIVE™ Network Surpasses 300 Million Patients, Expanding Decision-Grade Evidence Across Global Healthcare
The milestone reflects accelerating international growth and gives pharmaceutical companies, academic researchers, healthcare providers, and health-tech innovators access to trusted, current, clinically rich, and globally representative real-world data. CAMBRIDGE, Mass., June 23, 2026 /PRNewswire/ -- TriNetX, the world's leading federated health data network, today announced that its TriNetX LIVE™ network has...
Ambulatory Surgical Centres Poised for Sustained Growth as Healthcare Delivery Continues to Shift Beyond the Hospital
Frost & Sullivan identifies significant opportunities across ambulatory surgery, digital health, and connected care markets LONDON, June 23, 2026 /PRNewswire/ -- Frost & Sullivan's latest analysis highlights ambulatory surgical centres (ASCs) as one of the most significant growth opportunities reshaping healthcare delivery worldwide. Driven by rising demand for efficient, cost-effective, and patient-centric care, the global ASC market is...
BedStory® Launches BEDSTORY SPINEALIGN® and Cooling Collection Sleep Systems as Demand Grows for Precision-Tuned Support and Cooler Sleep
FOLSOM, Calif., June 23, 2026 /PRNewswire/ -- In response to growing consumer demand for sleep solutions that support both healthy sleep posture and thermal comfort, BedStory®, a family-focused healthy sleep brand trusted by millions of sleepers worldwide, today announced the North American launch of its new BEDSTORY SPINEALIGN® and Cooling Collection mattress series. The launch comes as the...
Fair Play Menarini International Award
Diego Milito and Emilio Butragueño among the winners of the 30th edition FLORENCE, Italy, June 23, 2026 /PRNewswire/ -- The list of winners of the 30th Fair Play Menarini International Award, scheduled for July 2 in Florence, continues to include great legends of world sport. Among the champions who will receive...
Ascletis Announces U.S. FDA IND Clearance for Phase I Study of Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for the Treatment of Obesity
Phase I trial consists of two parts. Part A is a single ascending dose (SAD) study of ASC35 once-monthly Self-Assembling Lipid Depot (SALD) formulation; Part B is a head-to-head study of multiple ascending doses (MAD) of ASC35 once-monthly SALD formulation compared to the U.S. Food and Drug Administration (FDA)-authorized tirzepatide...
WONTECH ASIA, THAILAND, Korean aesthetics leader, tops THB1bn revenue, up 39% with 40%+ RF market share; WAVE BANGKOK 2026 to spotlight Thailand’s medical potential globally
BANGKOK, June 23, 2026 /PRNewswire/ -- Thailand's beauty market, particularly the plastic surgery and aesthetic sector, was valued at approximately 75 billion baht in 2025. According to data from the TTB Economic Analysis Center (ttb analytics), the market expanded by more than 2.7% over the past year compared to the previous year. Although the growth rate slowed from...
